News

Hookipa Pharma debuts IPO

New York and Austria-based Hookipa Pharma, a developer of immunotherapeutics, has raised $84 million for its IPO after pricing its 6 million shares at $14 per share. The stock began trading April 18, 2019 on the NASDAQ under the ticker symbol “HOOK." BofA Merrill Lynch, SVB Leerink and RBC Capital Markets are the lead underwriters. Hookipa's pre-IPO backers included HBM Partners, Hillhouse Capital, Sirona Capital, Gilead, Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners.

Talaris lands $100 mln Series A

Boston and Louisville-based Talaris Therapeutics Inc, a biotechnology company, has secured $100 million in Series A financing. Blackstone Life Sciences led the round with participation from Longitude Capital and Qiming Venture Partners USA.

Arrakis Therapeutics rakes in $75 mln Series B

Waltham, Massachusetts-based Arrakis Therapeutics, a biopharmaceutical company, has raised $75 million in Series B funding. VenBio Partners and Nextech Invest led the round with participation from Omega Funds, HBM Healthcare Investments, GV, WuXi AppTec Venture Fund, Alexandria Venture Investments, Canaan Partners, Advent Life Sciences, Pfizer Ventures, Celgene Corporation, Osage University Partners and the estate of Henri Termeer.

Monthly recap of VC fundraising through April 15

Canadian VC begins 2019 with heft as top Q1 deals raise C$667 mln

Venrock's Willerer sees promise in Make School's bachelor's program with unusual tuition structure

Redox nabs $33 mln Series C

Redox, which provides a way for healthcare providers and vendors to share data, has raised $33 million in Series C funding. Battery Ventures led the round with participation from return backers .406 Ventures, RRE Ventures and Intermountain Ventures.

VC-backed EarlySense taps Johnson as CEO

Israel and Massachusetts-based EarlySense, a provider of continuous monitoring solutions for the healthcare continuum, has named Matt Johnson as CEO. He succeeds Avner Haperin, the company-co-founder and founding CEO who has led EarlySense since its 2004 launch. Johnson is a former managing director at Sowell & Co. EarlySense's backers include Hill-Rom, Wells Fargo Strategic Capital, BlueRed Capital, Israel Innovation Fund, Argos Capital, Hotung Capital, Pitango Venture Capital and JK&B Venture Capital.

Armory Square Ventures gathers $31 mln for sophomore fund

Armory Square Ventures has raised $31 million for its second fund, according to an SEC filing. No target was listed in the document. Armory Square Ventures is a seed and early-stage venture firm based in Syracuse, New York and New York City.

Industry Ventures receives minority investment from Goldman Sachs Asset Management’s Petershill Program

Industry Ventures said it received a minority investment from the Goldman Sachs Asset Management Petershill program. The size of the investment was not disclosed.